Evidence map›Paper›PMID 38301104›Full record

ArticleArchives of Iranian medicine2023

Monitoring the COVID-19 Vaccine Acceptance Trend and its Determinants Among Iranian Adults.

Leila Molaeipour, Ahmad Hajebi, Leila Janani, Masoud Salehi, Mohammad Hossein Taghdisi, Hajar Nazari-Kangavari, Neda Esmailzadehha, Fatemeh Varse, Nasrin Pourattar, Seyed Abbas Motevalian

Abstract read
In one paragraph

Article in Archives of Iranian medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Leila MolaeipourDepartment of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-1086-0907
Ahmad HajebiResearch Center for Addiction and Risky Behaviors (ReCARB), Psychosocial Health Research Institute (PHRI), Iran University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-8435-0398
Leila JananiImperial Clinical Trials Unit, School of Public Health, Faculty of Medicine, Imperial College London, London, United Kingdom.
Masoud SalehiDepartment of Biostatistics, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-9485-8371
Mohammad Hossein TaghdisiPublic Health Department, Faculty of Health and Medical Engineering, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.ORCID 0000-0003-3980-7998
Hajar Nazari-KangavariDepartment of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-6634-8139
Neda EsmailzadehhaDepartment of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-8109-6099
Fatemeh VarseDepartment of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-6165-4177
Nasrin PourattarDepartment of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-1706-4161
Seyed Abbas MotevalianDepartment of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-0404-4495

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVaccination seems to be the most critical means of halting the COVID-19 pandemic. It is crucial to understand the factors that influence COVID-19 vaccine acceptance to avoid low vaccination rates. This study intended to monitor the COVID-19 vaccine acceptance and its association with socio-demographic factors and prior diagnosis of COVID-19 in Iranian adults during the COVID-19 pandemic.

methodsThe study utilized data from the COVID-19 Population Survey of Iran (COPSIR), a repeated national survey designed to monitor COVID-19-related behavioral insights. From April 2020 to November 2021, thirteen iterations of a series of cross-sectional studies involving computer-assisted telephone interviews were conducted.

resultsThe COVID-19 vaccine acceptance rate remained above 80% until the ninth wave in February 2021, when it dropped to 62.9%. However, throughout the next four surveys, it rose gradually from 72.0% to 85.7%. The multilevel regression model revealed that the COVID-19 vaccine acceptance was significantly and positively linked with age and education.

conclusionDespite the relatively high COVID-19 vaccine acceptance rate among Iranian adults, after the emergence of vaccines on the global market and controversies about their safety in Iran, the initially high vaccine acceptance rate dropped significantly, and then increased over time and returned to its peak level (85%). According to the Commodity Theory, this rise in vaccine acceptance can be attributed to the COVID-19 vaccine shortage in the country between January and July 2022. For Iranian adults to accept vaccines more readily, health promotion programs should target the youth and the less literate adults.

Indexed as

COVID-19COVID-19 VaccinesAdolescentAdultCross-Sectional StudiesHumansIranPandemicsVaccinationCOVID-19 VaccinesCOVID-19COVID-19 vaccinesIranSARS-CoV-2Vaccines

Identifiers

PMID38301104
PMCPMC10685739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.